Abstract:AIM This study aimed to use one strain many compounds approach (OSMAC) to investigate the cytotoxic potential of Aspergillus terreus associated with soybean versus several cancer cell lines, by means of in-silico and in vitro approaches. METHODS AND RESULTS Fermentation of the isolated strain was done on five media. The derived extracts were investigated for their inhibitory activities against three human cancer cell lines; mammary gland breast cancer (MCF-7), colorectal adenocarcinoma (Caco-2) and hepatocellular carcinoma (HepG2) using MTT Assay. The fungal mycelia fermented in Modified Potato Dextrose Broth (MPDB) was the most cytotoxic extract against HepG2, MCF-7 and Caco-2 cell lines with IC50 4.2 ± 0.13, 5.9 ± 0.013 and 7.3 ± 0.004 µg.mL-1, respectively. MPDB extract was scaled up resulting in the isolation of six metabolites; three fatty acids (1, 2 and 4), one sterol (3) and two butenolides (5 and 6) by column chromatography. The isolated compounds (1-6) were screened through a molecular docking approach for their binding aptitude to various active sites. butyrolactone-I (5) revealed a significant interaction within the CDK2 active site, while aspulvinone E (6) showed promising binding affinity to FLT3 and EGFR active sites that was confirmed by in vitro CDK2, FLT3 and EGFR inhibitory activity. Finally, the in vitro cytotoxic activities of butyrolactone-I (5) and aspulvinone E (6) revealed the antiproliferative activity of butyrolactone-I (5), against HepG2 cell line (IC50 = 17.85 ± 0.32 µM). CONCLUSION Molecular docking analysis and in vitro assays suggested the CDK2/A2 inhibitory potential of butyrolactone-I (5) in addition to the promising interaction abilities of aspulvinone E (6) with EGFR and FLT3 active sites as a possible mechanism of their biological activities.

Butyrolactone I derivatives from Aspergillus terreus carrying an unusual sulfate moiety.

A butyrolactone derivative from marine-derived fungal strain Aspergillus terreus BTBU20211037

New Butenolide Derivatives from the Marine Sponge-Derived Fungus Aspergillus Terreus.

3″-Hydroxymethyl-butyrolactone II from Aspergillus sp

ChemInform Abstract: Bioactive Steroid Derivatives and Butyrolactone Derivatives from a Gorgonian‐Derived Aspergillus Sp. Fungus.

A New Sesquiterpenoid Derivative from the Coastal Saline Soil Fungus Aspergillus fumigatus

Bioactive Metabolites from Marine-Derived Streptomyces Sp A68 and Its Rifampicin Resistant Mutant Strain R-M1

Bioactive Secondary Metabolites from the Marine-Associated Fungus Aspergillus Terreus.

Asperterrestide A, A Cytotoxic Cyclic Tetrapeptide From The Marine-Derived Fungus Aspergillus Terreus Scsgaf0162

Cytotoxic and Antifungal Staurosporine Derivatives from Marine-Derived Actinomycete Streptomyces Sp. ZS-A121

New Butyrolactone Derivatives from the Endophytic Fungus Talaromyces Sp. CPCC 400783 of Reynoutria Japonica Houtt.

Two New Bioactive Steroids from a Mangrove-Derived Fungus Aspergillus Sp.

Structure Determination and Biosynthesis of the Antifungal Butyrolactols from Streptomyces Sp.

Asperimides A-D, Anti-Inflammatory Aromatic Butenolides from a Tropical Endophytic Fungus Aspergillus Terreus

Lactones From The Sponge-Derived Fungus Talaromyces Rugulosus

Anti-inflammatory butenolide derivatives from the coral-derived fungus Aspergillus terreus and structure revisions of aspernolides D and G, butyrolactone VI and 4′,8′′-diacetoxy butyrolactone VI

Structures and Antiviral Activities of Butyrolactone Derivatives Isolated from Aspergillus Terreus MXH-23

Promising Cytotoxic butenolides from the Soybean endophytic fungus Aspergillus terreus: a combined molecular docking and in-vitro studies.

Aureoterrolides B‒M: Eremophilane-type Sesquiterpenoids Isolated from Aspergillus Aureoterreus and Their Cytotoxicity.

Peptides and Polyketides Isolated from the Marine Sponge-Derived Fungus Aspergillus Terreus SCSIO 41008.

New Sulfurated Butyrolactones from the Fungus Penicillium janthinellum